Abstract
Tubular carcinoma of the breast, first described by Cornil and Ranvier in 1869 [5], is a rare variant of invasive breast cancer, characterized by well-differentiated, orderly tubule formation and associated with excellent patient outcomes. The outstanding prognosis of this disease has led some to investigate if it could be safely managed less aggressively than standard invasive ductal carcinoma (IDC). In recent years, the necessity of lymph node evaluation [7, 16, 36], systemic therapy [7], and radiation therapy for these patients have all been questioned [18, 30]. Yet, while some have advocated a more restrained approach to the management of this cancer, others have expressed reluctance at deviating from a standard of care that has produced such exceptional outcomes [29].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cabral AH, Recine M, Paramo JC et al. (2003) Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J 9: 298–301
Carstens PH (1978) Tubular carcinoma of the breast. A study of frequency. Am J Clin Pathol 70: 204–10
Carstens PH, Greenberg RA, Francis D et al. (1985) Tubular carcinoma of the breast. A long term follow-up. Histopathology 9: 271–80
Cooper HS, Patchefsky AS, Krall RA (1978) Tubular carcinoma of the breast. Cancer 42: 2334–42
Cornil V, Ranvier L (1869). Manuel d’histologie pathologique. Germer Bailliere, Paris
Deos PH, Norris HJ (1982) Well-differentiated (tubular) carcinoma of the breast. A clinicopathologic study of 145 pure and mixed cases. Am J Clin Pathol 78: 1–7
Diab SG, Clark GM, Osborne CK et al. (1999) Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17:1442–8
Early Breast Cancer Trialists’ Collaborative Group (2000) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355: 1757–70
Fein DA, Fowble BL, Hanlon AL et al. (1997) Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol 65: 34–9
Fyles AW, McCready DR, Manchul LA et al. (2004) Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer. N Engl J Med 351:963–70
Goldstein NS, Kestin LL, Vicini FA (2004) Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients. Am J Clin Pathol 122: 728–39
Haffty BG, Perrotta PL, Ward B et al. (1997) Conservatively treated breast cancer: outcome by histologic subtype. Breast J 3: 7–14
Holland DW, Boucher LD, Mortimer JE (2001) Tubular breast cancer experience at Washington University: a review of the literature. Clin Breast Cancer 2: 210–4
Hughes K, Schnaper LA, Berry D et al. (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 Years of age or older with early breast cancer. N Engl J Med 351: 971–7
Kader HA, Jackson J, Mates D et al. (2001) Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse. Breast J 7: 8–13
Kitchen PR, Smith TH, Henderson MA et al. (2001) Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy. ANZ J Surg 71: 27–31
Leikola J, Heikkilä P, Smitten KV et al. (2006) The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy. Eur J Surg Oncol 32: 488–91
Leonard CE, Howell K, Shapiro H et al. (2005) Excision only for tubular carcinoma of the breast. Breast J 11: 129–33
Livi L, Paiar F, Meldolesi E et al. (2005) Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. Eur J Surg Oncol 31: 9–12
McDivitt RW, Boyce W, Gersell D (1982) Tubular carcinoma of the breast. Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 6: 401–11
Northridge ME, Rhoads GG, Wartenberg D et al. (1997) The importance of histologic type on breast cancer survival. J Clin Epidemiol 50: 283–90
Oakley GJ, 3rd, Tubbs RR, Crowe J et al. (2006) HER-2 amplification in tubular carcinoma of the breast. Am J Clin Pathol 126: 55–8
Oberman HA, Fidler WJ Jr (1979) Tubular carcinoma of the breast. Am J Surg Pathol 3: 387–95
Papadatos G, Rangan AM, Psarianos T et al. (2001) Probability of axillary node involvement in patients with tubular carcinoma of the breast. Br J Surg 88: 860–4
Peters GN, Wolff M, Haagensen CD (1981) Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases. Ann Surg 193: 138–49
Rescigno J, Schiff PB (1997) Tubular carcinoma: Analysis of 1,623 patients from the SEER database (Abstr. 142). Breast Cancer Res Treat 46: 40
Schnitt SJ, Hayman J, Gelman R et al. (1996) A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77: 1094–100
Stalsberg H, Hartmann WH (2000) The delimitation of tubular carcinoma of the breast. Hum Pathol 31: 601–7
Sullivan T, Taghian AG (2006) Management of tubular carcinoma of the breast: general review. Curr Med Lit: Breast Cancer 18: 61–6
Sullivan T, Raad R, Goldberg S et al. (2005) Tubular Carcinoma of the Breast: a Retrospective Analysis and Review of the Literature. Breast Cancer Res Treat 93:199–205
Taghian AG, Recht A (2006) Update on accelerated partial-breast irradiation. Curr Oncol Rep 8: 35–41
Thurman SA, Schnitt SJ, Connolly JL et al. (2004) Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 59: 152–9
Tobon H, Salazar H (1977) Tubular carcinoma of the breast. Clinical, histological, and ultrastructural observations. Arch Pathol Lab Med 101: 310–6
Weiss MC, Fowble BL, Solin LJ et al. (1992) Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 23: 941–7
Williamson Z, Bradford MD, Wayne N et al. (1998) Treatment of Pure Tubular Carcinoma of the Breast. Breast J 4: 437–40
Winchester DJ, Sahin AA, Tucker SL et al. (1996) Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. Ann Surg 223: 342–7
Wong SL, Chao C, Edwards MJ et al. (2002) Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surg 184:492–8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Sullivan, T., Taghian, A.G. (2009). Tubular carcinoma of the breast. In: Belkacémi, Y., Mirimanoff, RO., Ozsahin, M. (eds) Management of Rare Adult Tumours. Springer, Paris. https://doi.org/10.1007/978-2-287-92246-6_37
Download citation
DOI: https://doi.org/10.1007/978-2-287-92246-6_37
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-92245-9
Online ISBN: 978-2-287-92246-6
eBook Packages: MedicineMedicine (R0)